Synopsis: Jeena Sikho Lifecare signs strategic MOU with Sat Kartar Life to expand Ayurveda reach via AI-driven patient acquisition, 15% revenue share, and new South India hospitals over three years.
A new partnership aims to combine AI-driven patient acquisition with clinical healthcare delivery across India. The Company has joined hands with Sat Kartar Life Limited. The two companies signed a Strategic Memorandum of Understanding on April 14, 2026. The deal aims to bring Ayurveda healthcare to more patients across India.
Jeena Sikho Lifecare Limited’s stock, with a market capitalisation of Rs. 8,440 crores, rose to Rs. 686.90, up of 3.89 percent from its previous closing price of Rs. 661.15. Furthermore, the stock over the past year has given a return of 46.3 percent.
The partnership splits responsibilities clearly between the two firms. Sat Kartar Life will handle patient finding, engagement, and referrals. Jeena Sikho will take over once a patient arrives running all diagnosis, treatment, and care. Therefore, clinical decisions stay fully in Jeena Sikho’s hands at all times.
Sat Kartar Life brings AI-driven tools and a large consumer health network to the table. Its data analytics systems will identify and route patients to Jeena Sikho’s hospitals. Together, the companies hope to serve patients across the full care journey from first awareness to long-term wellness.
The deal uses a revenue-sharing model. Jeena Sikho will pay Sat Kartar Life 15% of net billing value for outpatient and medicine cases. For admitted patients, the same 15% applies on the total bill. Importantly, payment only triggers after the patient actually pays not on leads or appointments alone.
Additionally, if a patient continues recurring treatment at Jeena Sikho, the 15% share continues as well. GST, discounts, and free treatments are all excluded from the calculation. Both sides will reconcile accounts monthly, with Jeena Sikho retaining full audit rights.
The MOU also covers future growth plans. Sat Kartar Life intends to build new Ayurveda hospitals and healthcare centres, especially in South India. The company will own and fund these facilities entirely. Jeena Sikho, however, will step in as the clinical and operations partner running day-to-day medical functions.
Furthermore, patient clinical data from consultations will belong exclusively to Jeena Sikho Lifecare. Each party keeps ownership of data it already held before the deal. This ensures clear accountability and data privacy throughout the arrangement.
Regulators need not worry about conflicts of interest here. The transaction falls outside the definition of a related-party deal under SEBI rules. Sat Kartar Life’s promoters have no connection to Jeena Sikho’s promoter group. The deal is fully at arm’s length.
The MOU runs for three years from the date of signing. Either party can exit with 30 days’ written notice. The agreement does not create a joint venture or any formal legal partnership between the companies. Both firms will operate as independent contractors throughout the collaboration.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Jeena Sikho Lifecare Jumps 4% After Signing 3-Year Deal with Sat Kartar Life appeared first on Trade Brains.